# Arvo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arvo

- Industry: Healthcare IT
- Headquarters: Rio De Janeiro, Brazil
- Website: www.arvo.com.br
- Total disclosed funding: $20M
- Latest round: Series A (Sep 17, 2025)
- Investors on record: 4

## About

Founded in 2022 and based in Rio De Janeiro, Brazil, Arvo Health LTDA., doing business as Arvo, operates as a healthcare technology company. In September 2025, Arvo raised USD 20 million in series A funding co-led by new investors Kaszek Ventures and Base10 Partners, with participation from returning investors Canary and K50 Ventures.

Arvo offers a healthcare payment integrity platform, which is an artificial intelligence-based platform that leverages machine learning technology to identify deviations in claims, flag potential fraud cases, and identify errors and fraud in healthcare transactions. The company addresses two primary areas: payment integrity, which ensures that claims are processed accurately and in compliance with industry standards; and anti-fraud, where the platform detects and prevents fraudulent activities within healthcare payments. The firm’s client portfolio includes Porto Saúde, Saúde Petrobras, Athena, and Unimed Nacional.

The company will use the September 2025 funding to expand operations in Brazil, improve its payment systems, launch new products, hire engineers and data scientists, and explore acquisitions.

## Funding rounds

- Series A, Sep 17, 2025, $20M — Kaszek Ventures, Base10 Partners, Canary, Actions Capital

## Investors

- Kaszek Ventures (https://capitalatlas.ai/funds/kaszek-ventures) — Series A
- Base10 Partners (https://capitalatlas.ai/funds/base10-partners) — Series A
- Canary (https://capitalatlas.ai/funds/canary) — Series A
- Actions Capital (https://capitalatlas.ai/funds/actions-capital) — Series A